For US Residents Only
For Healthcare Professionals

LIBTAYO works with your immune system to help treat the following types of cancer:

Advanced NSCLC

For a type of lung cancer called non–small cell lung cancer (NSCLC) in adults that has spread to other areas of your body or has not spread outside of your chest and cannot be treated with surgery, or chemotherapy with radiation or chemoradiation, and your tumor does not have an abnormal “EGFR,” “ALK,” or “ROS1” gene. LIBTAYO can be used in combination with chemotherapy or used alone:

ALK=anaplastic lymphoma kinase; EGFR=epidermal growth factor receptor; HHI=hedgehog pathway inhibitor; PD-L1=programmed death ligand 1; ROS1=ROS proto-oncogene 1,
receptor tyrosine kinase.